Capital Fund Management S.A. Clovis Oncology, Inc. Call Options Transaction History

Capital Fund Management S.A.

3 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2018 May 15, 2018	SELL	$50.12 - $67.72 $230,552 - $311,512	-4,600 Closed	0 $0
Q4 2017 Feb 09, 2018	SELL	$57.69 - $84.58 $363,447 - $532,854	-6,300 Reduced 57.8%	4,600 $313,000
Q3 2017 Nov 13, 2017	BUY	$67.17 - $84.81 $732,153 - $924,429	10,900	10,900 $898,000

166

Ticker CLVS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 144,480,000
Market Cap $13M
Description
Clovis Oncology, Inc., a biopharmaceutical company, focuses on acquiring, developing, and commercializing anti-cancer agents in the United States, Europe, and internationally. In the U.S., the company offers Rubraca (rucaparib), an oral small molecule inhibitor of poly ADP-ribose polymerase for recurrent epithelial ovarian, fallopian tube, or pr...

Get notified when there are updates to the investment portfolio of Capital Fund Management S.A., based on Form 13F filings with the SEC.

Stay updated on Capital Fund Management S.A. with notifications on news.